- Home
- GP vs EDSA Comparison
GP vs EDSA Comparison
Compare GP & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- EDSA
- Stock Information
- Founded
- GP 2010
- EDSA 2015
- Country
- GP Canada
- EDSA Canada
- Employees
- GP N/A
- EDSA N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- EDSA Health Care
- Exchange
- GP Nasdaq
- EDSA Nasdaq
- Market Cap
- GP 12.7M
- EDSA 13.8M
- IPO Year
- GP 2020
- EDSA N/A
- Fundamental
- Price
- GP $0.43
- EDSA $2.09
- Analyst Decision
- GP Strong Buy
- EDSA Strong Buy
- Analyst Count
- GP 2
- EDSA 2
- Target Price
- GP $2.33
- EDSA $13.00
- AVG Volume (30 Days)
- GP 84.8K
- EDSA 13.1K
- Earning Date
- GP 08-13-2025
- EDSA 08-08-2025
- Dividend Yield
- GP N/A
- EDSA N/A
- EPS Growth
- GP N/A
- EDSA N/A
- EPS
- GP N/A
- EDSA N/A
- Revenue
- GP $20,656,035.00
- EDSA N/A
- Revenue This Year
- GP N/A
- EDSA N/A
- Revenue Next Year
- GP $94.25
- EDSA N/A
- P/E Ratio
- GP N/A
- EDSA N/A
- Revenue Growth
- GP N/A
- EDSA N/A
- 52 Week Low
- GP $0.36
- EDSA $1.55
- 52 Week High
- GP $1.90
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- GP 55.17
- EDSA 55.09
- Support Level
- GP $0.38
- EDSA $2.03
- Resistance Level
- GP $0.43
- EDSA $2.11
- Average True Range (ATR)
- GP 0.03
- EDSA 0.10
- MACD
- GP 0.01
- EDSA 0.01
- Stochastic Oscillator
- GP 79.08
- EDSA 73.33
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.